The outcomes were:
• Discharged back to primary care = 51% o Patients seen and d/c after 1st appointment – 46.
o Patients no longer requiring appts – 19.
Patients DNA – 6
o
• Follow Up in Secondary care = 41% o Patients seen and upgraded to 2ww – 4. o Patients seen and upgraded to urgent – 13.
o Patients seen, given interim care and requiring further monitoring/surveillance/medication only prescribed in secondary care – 40. • Other = 8% o Patient requiring biopsies to be done at Lionwood Medical Practice (still under Community Dermatology Care) – 4 o Patients not able to make appts at Community Dermatology Care – so returned back to NNUH at their request – 8.
Spirometry Service Pilot
The Spirometry Pilots aim was to support the practices in carrying out the work required and directed by the Spirometry Locally Commissioned Service (LCS), commissioned by Norfolk and Waveney ICB (NWICB). NNPC worked collaboratively with Neo Health Care to undertake diagnostic spirometry, as per published quality services described in the Norfolk and Waveney LCS. The pilot commenced in February 2022, and will continue to roll into the 23/24 LCS spirometry service delivery plan. The delivery of the spirometry service is based on a local hub basis, with the patients attending their own Practice and having virtually assisted spirometry carried out. The innovative technology behind the testing uses remote analysis, which is then reported back to the patient’s G P. The pilot will deliver a service evaluation and could lead to a wider scale provision in North Norfolk, or beyond.
Cancer Services - Rapid Diagnostic Service
i)
Serious Non-Specific Symptoms (SNSS) Pathway
Since April 2021, NNPC was awarded a contract to provide a Rapid Diagnostic Service (RDS) across Norfolk & Waveney which supported the National Cancer Plan. The service is open to all patients that are not acutely unwell; are over the age of 18; and who have serious signs/symptoms that may indicate cancer, but do not meet the cancer 2 week wait pathway criteria (symptoms include for example, unexplained weight loss, fatigue, abdominal pain or GP “gut feeling” of cancer). It supports both Primary and Secondary Care in the assessment of patients who may otherwise be inappropriately referred on a 2 week wait cancer pathway which contributes to a delay in the diagnostic process. It operates from clinical sites in Norwich, Great Yarmouth, and Kings Lynn and can also fac ilitate virtual appointments where clinically appropriate.
The dedicated RDS team consists of four experienced part-time GP’s and a patient pathway coordinator. They all are able to be contacted by patients or referring clinicians throughout the
NNPC Quality Account 2022/23
10 | Pa g e
Made with FlippingBook Digital Proposal Creator